Clinical Case Database / Category: Clinical Care

Temporal arteritis

Publication details

Dr Kavitha Nadesalingam, Dr Sharmin Nizam, Dr Lesley Hordon
Foundation Years Journal, volume 6, issue 2, p.53 (123Doc Education, London, February 2012)

Abstract

Temporal arteritis (or giant cell arteritis) is a chronic vasculitis affecting large and medium vessels. We present a case based discussion encompassing the presentation, investigations, management and complications of temporal arteritis.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Dr Kavitha Nadesalingam

ST3 in Rheumatology at Dewsbury District Hospital

Dr Sharmin Nizam

SpR in Rheumatology at Dewsbury District Hospital

Dr Lesley Hordon

Consultant in Rheumatology at Dewsbury District Hospital

References

1. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990 to 2001. Ann Rheum Dis 2006;65:1093-8
2. Mukhtyar, Guillevin L, Cid MC et al. EULAR recommendations for the management of large cell vasculitis. Ann Rheum Dis 2009;68:318-23
3. Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE . How does previous glucocorticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92
4. Ray-Chauduri N, Kine DA, Tijani SO et al. Effect of prior glucocorticosteroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Opthamol 2002;86:530-2
5. Hunder GG, Bloch DA, Michael BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8
6. Kyle V. Treatment of polymyalgia rheumatica/giant cell arteritis. Baillieres Clin Rheumatol 1991;5:485-91
7. Heyreh SS, Zimmerman B, Kardon RH. Visual improvement with glucocorticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 2002;80:353-67
8. Chevalet P, Barrier J-H, Pottier P et al. A randomised multi-centre controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients. J Rheumatol 2000;27:1481-91
9. Mazlumzadeh M, Hunder GG, Easley KA et al. Treatment of giant cell arteritis using induction therapy with high dose glucocorticoids. Arthritis Rheum 2006;54:3310-8
10. Chan CCK, Paine M, O’Day J. Glucocorticosteroid management in giant cell arteritis. Br J Ophthalmol 2001;85:1061-4
11. Faroozan R, Deramo VA, Buono LM et al. Recovery of visual function in patients with biopsy proven giant cell arteritis. Opthalmology 2003;110:539-42
12. Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day glucocorticosteroid regimes in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 1975;82:613-8
13. Proven A, Gabriel SK, Orces C. et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8
14. Borg FA, Salter VLJ, Dasgupta B. Neuro-opthalmic complications in giant cell arteritis. Curr Allergy Asthma Rep 2008; 8:323-30
15. Nuenninghoff DM, Hunder GG, Christianson TJH et al. Incidence and predictors of large artery complication (aortic aneurysm, aortic dissection, and/or large artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003; 48:3522-31
16. Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Royal College of Physicians 2002

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.